These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 5821186)
1. Agnogenic myeloid metaplasia: role of splenectomy. Marks C; Ahmadi M Postgrad Med J; 1969 Apr; 45(522):261-5. PubMed ID: 5821186 [TBL] [Abstract][Full Text] [Related]
2. Agnogenic myeloid metaplasia; its current managment. Silverstein MN Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744 [No Abstract] [Full Text] [Related]
4. Influence of splenectomy on hemostasis in agnogenic myeloid metaplasia. Brenner B; Tavori S; Tatarsky I Haemostasis; 1987; 17(3):141-6. PubMed ID: 3609915 [TBL] [Abstract][Full Text] [Related]
5. 'Early' splenectomy and survival in agnogenic myeloid metaplasia. An analysis of 338 cases published since 1940. Benbassat J; Penchas S Acta Haematol; 1981; 65(3):189-92. PubMed ID: 6785973 [TBL] [Abstract][Full Text] [Related]
12. Splenectomy in patients with agnogenic myeloid metaplasia: an analysis of 321 published cases. Benbassat J; Penchas S; Ligumski M Br J Haematol; 1979 Jun; 42(2):207-14. PubMed ID: 465366 [TBL] [Abstract][Full Text] [Related]
13. The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia. Benbassat J; Gilon D; Penchas S Am J Hematol; 1990 Feb; 33(2):128-35. PubMed ID: 1689100 [TBL] [Abstract][Full Text] [Related]
14. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases. Brenner B; Nagler A; Tatarsky I; Hashmonai M Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384 [TBL] [Abstract][Full Text] [Related]
15. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Mesa RA; Elliott MA; Tefferi A Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148 [TBL] [Abstract][Full Text] [Related]
16. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia. Coleman TA; Hamill RL; Ford SM Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725 [No Abstract] [Full Text] [Related]
17. Experience with splenectomy in auto-immune thrombocytopenia and agnogenic myeloid metaplasia. Heaton A; Jacobs P; Dent DM; Louw JH S Afr Med J; 1976 Sep; 50(39):1506-12. PubMed ID: 988641 [TBL] [Abstract][Full Text] [Related]
18. Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis. Robin M; Espérou H; de Latour RP; Petropoulou AD; Xhaard A; Ribaud P; Socié G Br J Haematol; 2010 Sep; 150(6):721-4. PubMed ID: 20618333 [No Abstract] [Full Text] [Related]
19. Agnogenic myeloid metaplasia. Natural history and treatment. Silverstein MN; Gomes MR; ReMine WH; Elveback LR Arch Intern Med; 1967 Nov; 120(5):546-50. PubMed ID: 6054588 [No Abstract] [Full Text] [Related]
20. Subtotal splenectomy for treatment of patients with myelofibrosis and myeloid metaplasia. Petroianu A Int Surg; 1996; 81(2):177-9. PubMed ID: 8912088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]